Biotecnol and Cancer Research UK to assess Tb535H for solid tumours

Immune-oncology firm Biotecnol and Cancer Research UK have entered a collaboration agreement to evaluate Tb535H in clinical trials to treat patients suffering from solid tumours.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news